📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients. (2020)

First Author: Andersen HG

Attributed to: MRC Centre for Neurodevelopmental Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fnins.2020.00484

PubMed Identifier: 32508577

Publication URI: http://europepmc.org/abstract/MED/32508577

Type: Journal Article/Review

Volume: 14

Parent Publication: Frontiers in neuroscience

ISSN: 1662-453X